Japan Airlines Co 株価情報 (OTC: JPNRF)

最新ニュース Japan Airlines Co (OTC:JPNRF) 株価情報

Japan Airlines Co Ltd is an international air transport services company. It offers scheduled and nonscheduled air transport services and aerial work services. The company operates large aircraft, medium-size aircraft, small aircraft, and regional jets. JAL's route network comprises over 100 domestic routes and over 50 international routes. The airline flies to over 50 countries and regions and connects over 300 airports.

Boeing Stock Wiped Out 47% Of Investor Wealth Over The Last 5 Years Amid Multiple Issues — Now, This Expert Suggests A Breakup Could Benefit The Airplane Maker

News

European Aeronautic Defence And Space Unsponsored

EADSY

JAPSY

JPNRF

水曜日の発表によると、日本航空（Japan Airlines）（OTC:JAPSY）（OTC:JPNRF）がボーイング（Boeing Co.）（NYSE:BA）から、2023年3月に発注した2型21機に加え、17機のボーイング737-8型機を追加導入することを決定した。国内線の就航路線で使われている737-800型機の更新機材となる。

日本航空、ボーイング737-8機を追加導入決定

JAPAN AIRLINES CO JAL ORD by Japan Airlines Co Ltd JAL

Japan Airlines Co Ltd

President Donald Trump has invoked the Defense Production Act (DPA) to accelerate the development of the <a target="_blank" href="https://www.benzinga.com/markets/commodities" rel="noreferrer noopener">domestic mineral industry</a>, aiming to reduce the reliance on imports and bolster supply chains.
By signing an executive order on Thursday, Trump used the DPA, originally conceived by President Harry Truman, to mobilize industrial resources for national security. The act allows the government to provide financing, issue loans, and invest in projects that strengthen domestic mineral production and processing capabilities.
"The United States was once the world's largest producer of lucrative minerals, but overbearing federal regulation has eroded our nation's mineral production," Trump <a target="_blank" href="https://www.whitehouse.gov/presidential-actions/2025/03/immediate-measures-to-increase-american-mineral-production/" rel="noreferrer noopener">stated</a> in the executive order, clarifying the need to boost mining and refining operations as a national security measure.
His action calls for an expedited permitting process for domestic mining projects, which are <a target="_blank" href="https://www.benzinga.com/news/24/07/39870803/us-mine-development-delays-among-worlds-longest-second-only-to-zambia" rel="noreferrer noopener">among the slowest</a> in the world, along with increased federal land access for mineral extraction.
The U.S. International Development Finance Corporation, in coordination with the Department of Defense, is also set to provide financial support for new mining ventures.
The White House has long voiced concerns over the domestic dependence on foreign sources for critical minerals. President Joe Biden has <a target="_blank" href="https://www.benzinga.com/government/22/06/27559638/biden-set-to-announce-executive-order-to-revive-stalled-solar-projects-in-u-s-report" rel="noreferrer noopener">previously invoked DPA</a> to expand the production of battery metals, including lithium, nickel, and cobalt, recognizing the importance of these metals for many modern technologies – including batteries, semiconductors, defense systems, and green energy, and allowing companies to access $750 million in federal funding.
Trump's action goes further by expanding the list of priority minerals to include uranium, potash, and possibly coal – which he plans to leverage to bring down the cost of energy, <a target="_blank" href="https://in.benzinga.com/25/03/44375055/trump-turns-to-beautiful-clean-coal-to-address-domestic-energy-demand" rel="noreferrer noopener">helping industrial competitiveness</a>.
While China's 70% control over rare earth processing has been a concern, recent export restrictions of elements such as gallium and germanium have worsened the situation, raising concerns over supply shortages for U.S. manufacturers.
Besides boosting domestic production, Trump is also pursuing international agreements, including a <a target="_blank" href="http://e" rel="noreferrer noopener">potential deal with DR Congo</a> (the leading exporter of cobalt) and Ukraine.
"One of the things we are doing is signing a deal very shortly with respect to rare earths with Ukraine… They have tremendous value in rare earths, and we appreciate that," Trump said <a target="_blank" href="https://www.aljazeera.com/economy/2025/3/21/trump-orders-increased-minerals-production-says-ukraine-deal-coming-soon" rel="noreferrer noopener">per</a> Al Jazeera.
After weeks of negotiation, the deal regarding Ukraine's minerals fell through during Ukrainian President Volodymyr Zelensky's last visit to the White House, when tensions between the two leaders <a target="_blank" href="https://in.benzinga.com/news/global/25/02/44057033/this-is-something-that-president-trump-does-over-and-over-again-geopolitical-strategist-says-about-failed-rare-minerals-deal-with-ukraine-president-zelenskyy" rel="noreferrer noopener">derailed negotiations</a>. Since then, both sides have expressed willingness to move forward, signaling that the deal might happen soon.
Price Watch: Sprott Critical Materials (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SETM#NASDAQ">SETM</a>) is up 3.89% year-to-date.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/03/44414283/copper-surges-as-arbitrage-opportunity-drives-us-imports" target="_blank" rel="noreferrer noopener">Copper Surges As Arbitrage Opportunity Drives US Imports</a></li>
</ul>
Image via Shutterstock

Government

Financing

Commodities

Legal

Markets

FDTS

ISVL

NIKL

SETM

YDEC

Trump Invokes An Act From 1950s To Boost Domestic Mineral Industry

HC Wainwright &amp; Co. analyst Emily Bodnar reiterates Context Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CNTX#NASDAQ">CNTX</a>) with a Buy and maintains $5 price target.

Price Target

Reiteration

Analyst Ratings

CNTX

HC Wainwright & Co. Reiterates Buy on Context Therapeutics, Maintains $5 Price Target

Microchip Technology Incorporated (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MCHP#NASDAQ">MCHP</a>) shares are trading relatively flat on Friday<a target="_blank" href="https://www.benzinga.com/premarket" rel="noreferrer noopener"> in the premarket session.</a>
The firm has priced its <a target="_blank" href="https://www.benzinga.com/25/03/44413101/whats-going-on-microchip-technology-shares-premarket-on-thursday" rel="noreferrer noopener">previously </a>announced underwritten public offering of $1.35 billion of depositary shares, each representing a 1/20th interest in a share of newly issued 7.50% Series A Mandatory <a target="_blank" href="https://www.benzinga.com/pressreleases/25/03/g44429688/microchip-technology-announces-pricing-of-offering-of-depositary-shares-representing-interests-in-" rel="noreferrer noopener">Convertible Preferred Stock.</a>
The offering is priced at $50.00 per depositary share, with the offering expected to close on March 25.
Microchip has granted underwriters a 13-day option to purchase an additional $135 million of depositary shares to cover over-allotments.
The net proceeds, estimated at approximately $1.32 billion, will primarily be used to repay existing debt, including notes under the company's commercial paper program.
Also Read: <a target="_blank" href="https://www.benzinga.com/analyst-ratings/analyst-color/25/03/44423259/holley-may-bear-the-brunt-of-ongoing-macroeconomic-challenges-analyst-highlights-softer-top-line-outlook" rel="noreferrer noopener">Holley May Bear The Brunt Of Ongoing Macroeconomic Challenges, Analyst Highlights Softer Top-line Outlook</a>
Additionally, around $50.1 million will go towards paying for capped call transactions. If the over-allotment option is exercised, some of the proceeds will be directed toward additional capped call transactions.
In other news, Microchip recently introduced a new offering for the <a target="_blank" href="https://www.benzinga.com//node/44353847" rel="noreferrer noopener">electric two-wheeler (E2W) industry.</a>
The company's E2W ecosystem provides scalable solutions to optimize performance in electric scooters and bikes.
Key offerings include advanced battery management systems (BMS) that enhance power efficiency, extend battery life, and improve safety, helping manufacturers develop reliable, feature-rich products with quicker market entry.
As of December 31, cash and short-term&nbsp;<a target="_blank" href="https://www.benzinga.com/pressreleases/25/02/g43545040/microchip-technology-announces-financial-results-for-third-quarter-of-fiscal-year-2025" rel="noreferrer noopener">investments of the firm stood at $586 million</a>.
According to&nbsp;<a target="_blank" href="https://pro.benzinga.com/?gspk=YWRhbWVja2VydDUzMzY&amp;gsxid=zBMR4PKmcgBw" rel="noreferrer noopener">Benzinga Pro</a>, MCHP stock has lost over 42% in the past year. Investors can gain exposure to the stock via First Trust S&amp;P 500 Diversified Dividend Aristocrats ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KNGZ#NASDAQ">KNGZ</a>).
Price Action: MCHP shares are trading lower by 0.45% to $50.77 in the premarket session on Friday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/movers/25/03/44423418/amentum-faces-growth-slump-as-government-cuts-spending-analyst-expects-merger-to-boost-margins" target="_blank" rel="noreferrer noopener">Amentum Faces Growth Slump As Government Cuts Spending, Analyst Expects Merger To Boost Margins</a></li>
</ul>
Photo via Shutterstock.

Equities

Offerings

Movers

General

KNGZ

MCHP

What's Going On With Microchip Technology Stock Today?

Chardan Capital analyst Keay Nakae maintains Allurion Technologies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ALUR#NYSE">ALUR</a>) with a Neutral and announces $2.5 price target.

ALUR

Chardan Capital Maintains Neutral on Allurion Technologies, Announces $2.5 Price Target

B of A Securities analyst Craig Bijou maintains RxSight (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RXST#NASDAQ">RXST</a>) with a Buy and lowers the price target from $60 to $36.

RXST

B of A Securities Maintains Buy on RxSight, Lowers Price Target to $36

SNGX

Soligenix Reported Revenues Of $0.1M For Year Ended December 31, 2024, Compared To $0.8M YoY;  Company's Cash Position Was $7.8M

HC Wainwright &amp; Co. analyst Swayampakula Ramakanth maintains Vor Biopharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VOR#NASDAQ">VOR</a>) with a Buy and lowers the price target from $17.5 to $13.

HC Wainwright & Co. Maintains Buy on Vor Biopharma, Lowers Price Target to $13

23andMe Unveils New Homocysteine (MTHFR-Related) Genetic Report And Accompanying Lab Test

Anteris Reports One-Year Patient Outcomes For DurAVR THV: Says It Demonstrated Favorable Hemodynamic Profile Sustained To One year

AstraZeneca Announced Global Collaboration With Harbour BioMed To Develop Next-Gen Therapeutic Antibodies, Including $105M Equity Investment, $175M Upfront, Up To $4.4B In Milestones, And Acquisition Of 9.15% Newly Issued Shares Of Harbour BioMed

Needham analyst Ryan MacDonald reiterates Agilon Health (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AGL#NYSE">AGL</a>) from Hold to Hold.

Needham Reiterates Hold on Agilon Healthto Hold

Chardan Capital analyst Keay Nakae maintains Alnylam Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALNY#NASDAQ">ALNY</a>) with a Buy and maintains $300 price target.

ALNY

Chardan Capital Maintains Buy on Alnylam Pharmaceuticals, Maintains $300 Price Target

HC Wainwright &amp; Co. analyst Swayampakula Ramakanth maintains Elevation Oncology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ELEV#NASDAQ">ELEV</a>) with a Buy and lowers the price target from $6 to $1.

ELEV

HC Wainwright & Co. Maintains Buy on Elevation Oncology, Lowers Price Target to $1

Chinese electric vehicle maker&nbsp;NIO, Inc&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NIO#NYSE">NIO</a>) shares are trading lower premarket on Friday after the company reported fiscal&nbsp;fourth-quarter&nbsp;revenue of 19.70 billion Chinese yuan&nbsp;($2.70 billion), up 15.2%&nbsp;year-over-year and up&nbsp;5.5%&nbsp;sequentially. Analysts, on average, estimated <a target="_blank" href="https://www.benzinga.com/pressreleases/25/03/g44431868/nio-inc-reports-unaudited-fourth-quarter-and-full-year-2024-financial-results" rel="noreferrer noopener">revenue of&nbsp;$2.85 billion for the quarter</a>.
Excluding items, the company reported an adjusted loss per share per ADS of 3.17 Chinese yuan or 43 cent loss compared to a 2.81 Chinese <a target="_blank" href="https://www.benzinga.com/earnings" rel="noreferrer noopener">yuan loss in the year-ago quarter</a>. Analysts had called for a&nbsp;<a target="_blank" href="https://www.benzinga.com/calendars/earnings" rel="noreferrer noopener">loss of 42 cents per ADS</a>.
Vehicle deliveries were 72,689&nbsp;in the quarter, up&nbsp;45.2%&nbsp;Y/Y and&nbsp;17.5%&nbsp;Q/Q. Consequently, vehicle revenue rose by&nbsp;13.2%&nbsp;Y/Y and increased by&nbsp;4.7%&nbsp;Q/Q.
Nio delivered 13,863&nbsp;vehicles in January 2025 and 13,192 vehicles in February 2025. As of February 28, 2025, the cumulative number of NIO vehicle deliveries reached 698,619.
Gross margin for the quarter expanded to&nbsp;11.7%, up from&nbsp;7.5%&nbsp;a year ago and&nbsp;10.7%&nbsp;the previous quarter, as vehicle margin expanded Y/Y from&nbsp;11.9%&nbsp;a year ago to&nbsp;13.1%.&nbsp;
As of December 31, 2024, cash and cash equivalents, restricted cash, short-term investments, and long-term time deposits totaled 41.9 billion Chinese yuan&nbsp;($5.7 billion).
Read: <a target="_blank" href="https://www.benzinga.com/25/03/44424848/nio-q4-earnings-preview-catl-battery-swap-deal-onvo-vehicles-top-items-to-watch" rel="noreferrer noopener">Nio Q4 Earnings Preview: CATL Battery Swap Deal, ONVO Vehicles Top Items To Watch</a>
NIO founder, Chair, and CEO William Bin Li said, &#8220;In 2024, we achieved a new delivery record of 221,970 vehicles. Throughout the year, NIO brand maintained its position as the leader in China&#8217;s BEV market for vehicles priced over RMB300,000, capturing a 40% market share.&#8221;
&#8220;The market share of the ONVO L60 has been steadily increasing since its launch, securing a top-three position in China&#8217;s BEV SUV market priced between RMB200,000 and 300,000.&#8221;&nbsp;
&#8220;NIO brand will further solidify its premium positioning by introducing more technology and experience-driven products. ONVO brand, targeting the mainstream mass market, will concentrate on increasing its sales volume and enriching its product portfolio. Firefly&#8217;s model will be officially launched and begin deliveries in April, serving as a key driver for our future international expansion.&#8221;
Outlook: NIO expects first-quarter deliveries of 41,000 and 43,000 vehicles, reflecting a<a target="_blank" href="https://www.benzinga.com/calendars/guidance" rel="noreferrer noopener"> Y/Y increase of 36.4% to 43.1%</a>.
The company projects revenues between RMB12.367 billion ($1.694 billion) and RMB12.859 billion ($1.762 billion), representing an increase of approximately&nbsp;24.8%&nbsp;&#8211; 29.8%&nbsp;from the same quarter of 2024.
Investors can gain exposure to the stock via&nbsp;Invesco Golden Dragon China ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PGJ#NASDAQ">PGJ</a>) and VanEck Low Carbon Energy ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SMOG#NYSE">SMOG</a>).
Price Action: NIO shares are down 4.25% at $4.52 premarket at the last check Friday.
Also Read:
<ul>
<li><a href="https://www.benzinga.com/25/03/44431990/us-stocks-likely-to-open-lower-economic-conditions-dont-signal-a-downturn-say-analysts-as-they-expect-resilient-earnings-to-lift-equities" target="_blank" rel="noreferrer noopener">US Stocks Likely To Open Lower, But &#8216;Economic Conditions Don&#8217;t Signal A Downturn,&#8217; Say Analysts As They Expect &#8216;Resilient Earnings&#8217; To Lift Equities</a></li>
</ul>
Photo by Sundry Photography on Shutterstock.

Earnings

Large Cap

Guidance

PowerShares Golden Dragon Halter USX China Portfolio

SMOG

NIO Q4 Earnings: Revenue & EPS Miss, 45% Delivery Growth, Margin Gains And More

Raymond James analyst Daniel Tamayo initiates coverage on ACNB (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACNB#NASDAQ">ACNB</a>) with a Outperform rating and announces Price Target of $47.

Initiation

ACNB

Raymond James Initiates Coverage On ACNB with Outperform Rating, Announces Price Target of $47

HC Wainwright &amp; Co. analyst Edward White reiterates InflaRx (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IFRX#NASDAQ">IFRX</a>) with a Buy and maintains $8 price target.

IFRX

HC Wainwright & Co. Reiterates Buy on InflaRx, Maintains $8 Price Target

Rosenblatt analyst Kevin Garrigan maintains Ouster (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OUST#NASDAQ">OUST</a>) with a Buy and maintains $17 price target.

OUST

Rosenblatt Maintains Buy on Ouster, Maintains $17 Price Target

HC Wainwright &amp; Co. analyst Edward White reiterates Valneva (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VALN#NASDAQ">VALN</a>) with a Buy and maintains $17 price target.

VALN

HC Wainwright & Co. Reiterates Buy on Valneva, Maintains $17 Price Target

Biofrontera (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BFRI#NASDAQ">BFRI</a>) reported quarterly losses of $(3.22) per share which missed the analyst consensus estimate of $(0.85) by 278.82 percent. This is a 75.27 percent increase over losses of $(13.02) per share from the same period last year. The company reported quarterly sales of $37.32 million which missed the analyst consensus estimate of $47.06 million by 20.69 percent. This is a 9.54 percent increase over sales of $34.07 million the same period last year.

BFRI

Biofrontera FY 2024 GAAP EPS $(3.22) May Not Be Comparable To $(0.85) Estimate, Sales $37.32M Miss $47.06M Estimate

Piper Sandler analyst Jessica Tassan maintains CVS Health (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CVS#NYSE">CVS</a>) with a Overweight and raises the price target from $72 to $74.

Piper Sandler Maintains Overweight on CVS Health, Raises Price Target to $74

Small Cap

Press Releases

Private High-Speed Rail Pioneer iryo Becomes First UATP Rail Merchant in Spain

ACDVF

ANZFF

ANZLY

GOLLQ

QABSY

QUBSF

TKHVY

TSX:AC

Japan Airlines Co

水曜日の発表によると、日本航空（OTC:<a class="ticker" href="https://www.benzinga.com/stock/JAPSY#OTC">JAPSY</a>）（OTC:<a class="ticker" href="https://www.benzinga.com/stock/JPNRF#OTC">JPNRF</a>）がボーイング（NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BA#NYSE">BA</a>）から、2023年3月に発注した2型21機に加え、17機の<a href="https://www.benzinga.com/topic/boeing">ボーイング737-8型機</a>を追加導入することを決定した。国内線の就航路線で使われている737-800型機の更新機材となる。
日本航空は、羽田空港へと向かう便でボーイング767型機の代わりに、11機のエアバス（OTC:<a class="ticker" href="https://www.benzinga.com/stock/EADSY#OTC">EADSY</a>）A321型機を導入する。さらに、需要に合わせて機材の<a href="https://press.jal.co.jp/en/release/202503/008713.html">アップグレード</a>も可能となり、収益が期待される。
国際線では、日本航空はボーイング787-9型機10機とエアバスA350-900型機20機を新たに運用する予定とし、同社のLCC（格安航空会社）であるZIPAIRは、日本航空から再配置を受けた787-9型機を運行予定だ。2030会計年度までに、グループは北米とアジアといった高成長の需要を持つ多くの路線での収益性の向上に注力し、2023会計年度に比べて国際ビジネスを1.5倍に拡大することを目指している。
新たに発注した737-8型機を追加することで、日本航空グループの総機材数は約90機になる。日本航空は、2030年以降の長期的成長に向けての機材発注を行い、機材戦略を追求している。
次を読む：
<a href="https://www.benzinga.com/general/space/25/03/44391875/sunita-williams-butch-wilmore-return-to-earth-on-spacex-dragon-capsule-after-286-days-in-space-nasa-astronauts-to-undergo-health-checks" target="_blank" rel="noreferrer noopener">「286日間の宇宙滞在を終えて、スニータ・ウィリアムズ氏とウィルモア・ウィルモア氏がスペースXのドラゴンキャプセルで地球に帰還」</a>
ボーイングからの追加発注で、日本航空グループの総機材数は約90機に達する。日本航空は、2030年を超える長期的成長に向けた機材戦略に向かっている。
ボーイングは3月中旬、トランプ大統領による貿易戦争の激化を受けて、新たな<a href="https://www.benzinga.com/news/25/03/44346571/trade-war-may-boost-airbus-over-boeing-aercap-ceo-says-no-ones-going-to-want-to-pay-that">圧力</a>がかかった。ボーイング787型機の価格は最大4000万ドルに増加する可能性あり、関税によって航空会社は新たにエアバスを選ぶ可能性があるとエアキャップ（NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AER#NYSE">AER</a>）のエンガス・ケリー(Aengus Kelly)氏はコメントしている。エアバスはアラバマ州、ミシシッピ州、フロリダ州に施設があるため、関税を乗り切るのに有意な立場かもしれない。
なお、2月の納品更新情報を受けて、ゴールドマン・サックスのアナリストのノア・ポポナック(Noah Poponak)氏は、ボーイングの目標株価を213ドルで買い推奨を<a href="https://www.benzinga.com/25/03/44308485/goldman-sachs-sees-big-gains-for-boeing-as-orders-stack-up" target="_blank" rel="noreferrer noopener">再確認</a>。ボーイングは合計44機の航空機を納品し、そのうち31機が737 MAX型機である。これは、ボーイングが堅調であることを意味している。ポポナック氏は、2025年の生産の拡大と27会計年度の収益が1兆5100億ドルに達すると予測している。
株価の動向： 水曜日のボーイングの終値は前場で0.52％高の173.51ドル。
写真：<a href="https://www.benzinga.com/press-releases/21/07/p22054847/boeing-737-8-ja876j-3">Shutterstock</a>

Comments

Japan Airlines Co

ニュース

最新ニュース Japan Airlines Co (OTC:JPNRF) 株価情報

水曜日, 3 19, 2025

ニュース

パートナーシップ

ベンジンガ・グローバル